Viewing Study NCT05887167

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2026-05-20 @ 1:47 AM
Study NCT ID: NCT05887167
Status: RECRUITING
Last Update Posted: 2025-09-09
First Post: 2023-05-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Sponsor: Joshua Sasine, MD, PhD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Malignancy View
None Large B-cell Lymphoma View
None Acute Lymphoblastic Leukemia View
None Mantle Cell Lymphoma View
None Multiple Myeloma View
None Diffuse Large B Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR T-cell therapy View
None autologous hematopoietic stem cells View
None CAR T View
None CAR T therapy View